Faily Sara, Perveen Rahat, Chandler Kate, Clayton-Smith Jill
Manchester Centre for Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.
Cleft Palate Craniofac J. 2020 May;57(5):606-615. doi: 10.1177/1055665620902880. Epub 2020 Feb 17.
Oral-facial-digital syndrome type 1 (OFD1) [OMIM 311200] is a rare genetic disorder associated with congenital anomalies of the oral cavity, face, and digits. This condition is associated with mutations in the gene. Our objective was to recruit patients with the OFD1 clinical phenotype without genetic confirmation, aiming to identify genetic variants in the gene.
Three patients from 2 unrelated families were recruited into our study. We employed a variety of genomic techniques on these patients, including candidate gene analysis, array comparative genomic hybridization, whole-exome sequencing, and whole-genome sequencing.
We investigated 3 affected patients from 2 unrelated families with a clinical diagnosis of OFD1. We discovered a novel pathogenic dominant missense mutation c.635G>C (p.Arg212Pro) in the gene in one family. A novel frameshift, loss-of-function mutation c.306delA (p.Glu103LysfsTer42) was detected in the affected patient in the second family.
These new genetic variants will add to the spectrum of known mutations associated with the OFD1 disorder. Our study also confirms the variable phenotypic presentation of OFD1 and its well-recognized association with central nervous system malformations and renal anomalies. Molecular diagnostic confirmation achieved in these families will have positive implications for their medical management.
1型口面指综合征(OFD1)[OMIM 311200]是一种罕见的遗传性疾病,与口腔、面部和手指的先天性异常有关。这种疾病与该基因的突变有关。我们的目的是招募具有OFD1临床表型但未经基因确认的患者,旨在鉴定该基因中的遗传变异。
从2个无关家庭招募了3名患者纳入我们的研究。我们对这些患者采用了多种基因组技术,包括候选基因分析、阵列比较基因组杂交、全外显子组测序和全基因组测序。
我们调查了来自2个无关家庭的3名临床诊断为OFD1的患者。我们在一个家庭的该基因中发现了一个新的致病性显性错义突变c.635G>C(p.Arg212Pro)。在第二个家庭的患病患者中检测到一个新的移码、功能丧失突变c.306delA(p.Glu103LysfsTer42)。
这些新的遗传变异将增加与OFD1疾病相关的已知突变谱。我们的研究还证实了OFD1的可变表型表现及其与中枢神经系统畸形和肾脏异常的公认关联。在这些家庭中实现的分子诊断确认将对他们的医疗管理产生积极影响。